Primary and Secondary Prevention of Stroke and Systemic Embolism With Rivaroxaban in Patients With Non-Valvular Atrial Fibrillation
Heart and Vessels - Japan
doi 10.1007/s00380-018-1219-0
Full Text
Open PDFAbstract
Available in full text
Date
July 6, 2018
Authors
Publisher
Springer Science and Business Media LLC